Related Experiment Video
Updated: Aug 19, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Risk management. Recommendations for the freestanding oncology center. Part two
Abstract:
Risk management is an active ongoing process for identification and management of possible losses. It is no longer possible, in this day of escalating numbers of suits and escalating dollar amounts for damages, to solely manage this by transfer of liability through insurance. An active program, in order to reduce the potential for liability, needs to be implemented and needs to be continued on an active ongoing basis, even in the freestanding radiation oncology center. This will require expenditure of time and dollars for periodic review by consultants, but will pay handsome rewards by reducing the potential for loss.
More Related Videos
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
05:18Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
Published on: October 6, 2023
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Standards of Care I
Standards of Care II
Cancer Survival Analysis